Imaging ndings and differential diagnosis of hepatic sinusoidal occlusion syndrome and Budd- Chiari syndrome

Cui yu Jia (  jiacuiyu@ccmu.edu.cn ) Beijing YouAn Hospital, Capital Medical University Da wei Zhao (  zhaoDW8999@163.com ) Beijing YouAn Hospital, Capital Medical University Ji liang Feng Beijing YouAn Hospital, Capital Medical University Rui li Li Beijing YouAn Hospital, Capital Medical University Xin xin Wang Beijing YouAn Hospital, Capital Medical University Hong jun Li (  lihongjun00113@ccmu.edu.cn ) Beijing YouAn Hospital, Capital Medical University

[1]  F. Ravaioli,et al.  Diagnosis and Treatment of VOD/SOS After Allogeneic Hematopoietic Stem Cell Transplantation , 2020, Frontiers in Immunology.

[2]  Lingling Meng,et al.  Clinical characteristics, CT signs, and pathological findings of Pyrrolizidine alkaloids-induced sinusoidal obstructive syndrome: a retrospective study , 2020, BMC Gastroenterology.

[3]  V. Vilgrain,et al.  CT and MR imaging of chemotherapy-induced hepatopathy , 2019, Abdominal Radiology.

[4]  Jianming Xu,et al.  Quantitative Analysis of CT Images in Patients with Pyrrolizidine Alkaloid-Induced Sinusoidal Obstruction Syndrome , 2019, Scientific Reports.

[5]  T. Bai,et al.  Gadoxetic Acid-Enhanced Hepatobiliary-Phase Magnetic Resonance Imaging for Pyrrolizidine Alkaloid-Induced Hepatic Sinusoidal Obstruction Syndrome and Association with Liver Function , 2019, Scientific Reports.

[6]  Varun Bansal,et al.  Budd-Chiari syndrome: imaging review. , 2018, The British journal of radiology.

[7]  A. Schulz,et al.  Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in pediatric patients: a new classification from the European society for blood and marrow transplantation , 2017, Bone Marrow Transplantation.

[8]  M. Ronot,et al.  Diagnosis of Budd–Chiari syndrome , 2018, Abdominal Radiology.

[9]  T. Genet,et al.  Diagnostic performance of contrast-enhanced CT-scan in sinusoidal obstruction syndrome induced by chemotherapy of colorectal liver metastases: Radio-pathological correlation. , 2017, European journal of radiology.

[10]  X. Hou,et al.  Diagnostic performance of Contrast-enhanced CT in Pyrrolizidine Alkaloids-induced Hepatic Sinusoidal Obstructive Syndrome , 2016, Scientific Reports.

[11]  M. Abecassis,et al.  Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation , 2016, Bone Marrow Transplantation.

[12]  O. Matsui,et al.  Correlation between Gd-EOB-DTPA-enhanced MR imaging findings and OATP1B3 expression in chemotherapy-associated sinusoidal obstruction syndrome , 2015, Abdominal Imaging.

[13]  Min Ju Kim,et al.  Hepatic Parenchymal Heterogeneity on Contrast-enhanced CT Scans Following Oxaliplatin-based Chemotherapy: Natural History and Association with Clinical Evidence of Sinusoidal Obstruction Syndrome. , 2015, Radiology.

[14]  J. Crawford,et al.  Sinusoidal obstruction syndrome (hepatic veno-occlusive disease). , 2014, Journal of Clinical and Experimental Hepatology.

[15]  Yi-Xiang J. Wang,et al.  Hepatic Sinusoidal Obstruction Syndrome Caused by Herbal Medicine: CT and MRI Features , 2014, Korean journal of radiology.

[16]  Hong Gao,et al.  Tusanqi and hepatic sinusoidal obstruction syndrome , 2014, Journal of digestive diseases.

[17]  G. Lin,et al.  Definitive diagnosis of hepatic sinusoidal obstruction syndrome induced by pyrrolizidine alkaloids , 2012, Journal of digestive diseases.

[18]  G. Lin,et al.  Hepatic sinusoidal obstruction syndrome associated with consumption of Gynura segetum. , 2011, Journal of hepatology.

[19]  L. Rubbia‐Brandt,et al.  Sinusoidal obstruction syndrome. , 2010, Clinics in liver disease.

[20]  J. Huo,et al.  Hepatic veno-occlusive disease associated with toxicity of pyrrolizidine alkaloids in herbal preparations. , 2010, The Netherlands journal of medicine.

[21]  Allen R. Chen,et al.  Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome. , 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[22]  Y. Bayraktar,et al.  Budd-Chiari syndrome: etiology, pathogenesis and diagnosis. , 2007, World journal of gastroenterology.

[23]  Yan Jiang,et al.  Deacetylclivorine: A Gender-Selective Metabolite of Clivorine Formed in Female Sprague-Dawley Rat Liver Microsomes , 2007, Drug Metabolism and Disposition.

[24]  Sukru Mehmet Erturk,et al.  CT features of hepatic venoocclusive disease and hepatic graft-versus-host disease in patients after hematopoietic stem cell transplantation. , 2006, AJR. American journal of roentgenology.

[25]  D. Mitchell,et al.  Budd‐chiari syndrome: Spectrum of appearances of acute, subacute, and chronic disease with magnetic resonance imaging , 2000, Journal of magnetic resonance imaging : JMRI.

[26]  M. Kami,et al.  Risk factors for hepatic veno-occlusive disease after bone marrow transplantation: retrospective analysis of 137 cases at a single institution , 1997, Bone Marrow Transplantation.

[27]  K. Tınaztepe,et al.  Veno-occlusive disease of the liver. , 1967, The Turkish journal of pediatrics.

[28]  H. Stein.  Veno-occlusive Disease of Liver in African Children , 1957, British medical journal.